Cochrane Abstracts
Rofecoxib for osteoarthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rofecoxib for Osteoarthritis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439050/all/Rofecoxib_for_osteoarthritis.
Rofecoxib for osteoarthritis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439050/all/Rofecoxib_for_osteoarthritis. Accessed October 30, 2025.
Rofecoxib for osteoarthritis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439050/all/Rofecoxib_for_osteoarthritis
Rofecoxib for Osteoarthritis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 October 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439050/all/Rofecoxib_for_osteoarthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rofecoxib for osteoarthritis
ID - 439050
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439050/all/Rofecoxib_for_osteoarthritis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
